Literature DB >> 8440936

Experimental Lyme disease in dogs produces arthritis and persistent infection.

M J Appel1, S Allan, R H Jacobson, T L Lauderdale, Y F Chang, S J Shin, J W Thomford, R J Todhunter, B A Summers.   

Abstract

Lyme disease was reproduced in specific pathogen-free beagle dogs by exposure to Borrelia burgdorferi-infected ticks (Ixodes dammini). Seroconversion and disease frequency were higher after exposure to infected adult ticks than to infected nymphs. Young pups developed clinical disease more readily than older dogs. The incubation period lasted 2-5 months. Acute recurrent lameness with fibrinopurulent arthritis was the dominant clinical sign. Dogs recovered but developed persistent mild polyarthritis. B. burgdorferi persisted in recovered dogs for at least 1 year. Isolation of B. burgdorferi and detection by polymerase chain reaction was most successful from skin biopsies at the site of the tick bite. Antibody to B. burgdorferi antigens was first detected by ELISA and Western blots by 4-6 weeks after exposure. High serum levels persisted during 17 months of observation. In contrast to infection from ticks, inoculation of dogs with cultured B. burgdorferi resulted in seroconversion with a shorter duration of antibody persistence and no clinical disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440936     DOI: 10.1093/infdis/167.3.651

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  62 in total

1.  PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period.

Authors:  R K Straubinger
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters.

Authors:  B K Du Chateau; D M England; S M Callister; L C Lim; S D Lovrich; R F Schell
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi.

Authors:  C L Croke; E L Munson; S D Lovrich; J A Christopherson; M C Remington; D M England; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Serological confirmation of Borrelia burgdorferi infection in dogs in the Czech Republic.

Authors:  K Pejchalová; A Zákovská; K Fucík; P Schánilec
Journal:  Vet Res Commun       Date:  2006-04       Impact factor: 2.459

5.  Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.

Authors:  Nikola Pantchev; Silvia Pluta; Elke Huisinga; Stephanie Nather; Miriam Scheufelen; Majda Globokar Vrhovec; Andrea Schweinitz; Herwig Hampel; Reinhard K Straubinger
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

6.  Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.

Authors:  Y F Chang; M J Appel; R H Jacobson; S J Shin; P Harpending; R Straubinger; L A Patrican; H Mohammed; B A Summers
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 7.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

8.  A guinea pig model for Lyme disease.

Authors:  S W Sonnesyn; J C Manivel; R C Johnson; J L Goodman
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.

Authors:  S W Barthold; L K Bockenstedt
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

Authors:  Rhonda L LaFleur; Jennifer C Dant; Terri L Wasmoen; Steven M Callister; Dean A Jobe; Steven D Lovrich; Thomas F Warner; O Abdelmagid; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.